MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Scans Without Evidence of Dopamine Deficiency (SWEDD) in Early-Onset Parkinson’s Disease: Comprehensive Clinical Analysis

    A. Zare Dehnavi, C. Piat, A. Mullan, P. Turcano, E. Camerucci, M. Derhab, R. Savica (Rochester, USA)

    Objective: Aim of this study is to comprehensively compare motor and non-motor symptoms of individuals with Early Onset Parkinson's Disease (EOPD) with dopamine deficiency to…
  • 2025 International Congress

    Using Multi-Generational High-Risk Pedigrees to Identify Candidate Parkinson’s Disease Predisposition Genes

    P. Moretti, K. Allen-Brady, J. Stevens, K. Figueroa, S. Pulst, L. Cannon-Albright (Salt Lake City, USA)

    Objective: To identify rare genetic variants associated with increased risk of Parkinson’s disease (PD) in multi-generational, high-risk pedigrees. Background: Our current knowledge of PD genetics…
  • 2025 International Congress

    Mutations of the VPS13A gene in a patient with Early-Onset Parkinson’s Disease: A case report.

    H. Pacheco, V. Gómez, C. Sánchez, L. Núñez (Mexico, Mexico)

    Objective: To describe the case of a patient with early-onset Parkinson's Disease (PD) with variants of the VPS13A gene. Background: The vacuolar protein sorting 13A…
  • 2025 International Congress

    European-Derived Parkinson’s Disease Polygenic Risk Score Model Is Associated With PD Status, UPDRS Score But Not Age At Onset Or Cognitive Impairment In An Egyptian PD Dataset

    S. El-Shafie, A. Nagano, I. Elsayed, E. Khedr, M. William, A. El-Hosseiny, A. Shalash, G. Fawi, M. Yousef, S. El-Jaafary, H. Lee, A. Jama, M. Koraym, Y. Salah, A. Atputhavadivel, S. Elfarrash, Y. Elsaid, A. Gabr, N. Shebl, L. Aly, N. Abdelwahhab, T. Belal, N. Elsayed, M. El-Gamal, S. Elgamal, S. Ragab, J. Mekky, H. Houlden, M. Salama, M. Rizig (Cairo, Egypt)

    Objective: To assess the predictive ability of European-derived PD PRS model of 90 risk SNPs identified from the largest PD GWAS[1]in Egyptians and study its…
  • 2025 International Congress

    Genome-wide Association Analyses Reveal Susceptibility Variants Linked to Parkinson’s Disease in the South African Population Using Inferred Global and Local Ancestry

    K. Step, T. Peixoto Leal, E. Waldo, L. Madula, Y. Swart, C. Hernández, S. Bandres-Ciga, J. Kim, I. Mata, S. Bardien (Cape Town, South Africa)

    Objective: The study aimed to investigate genetic risk factors for Parkinson’s disease (PD) in an admixed South African cohort using GWAS and local ancestry (LA)-GWAS…
  • 2025 International Congress

    A Pan-Indian Genome-Wide Association Study of Parkinson’s Disease

    A. Kishore, A. Sreelatha, A. Tenghe, R. Borgohain, D. Puthenveedu, R. Rajan, L. Ricardo, P. Pal, R. Mridula, M. Urulangod, R. Yadav, S. Mehta, H. Kumar, P. Agarwal, N. Kumar, P. Kukkle, S. Desai, M. Sharma (Tubingen, Germany)

    Objective: To conduct the first pan-Indian genomic survey of PD across18 centres in India which included 4806 cases and 6363 controls. Background: The genetic architecture…
  • 2025 International Congress

    Motor Outcomes Following Subthalamic Nucleus or Globus Pallidus Interna Deep Brain Stimulation in Early-Onset Parkinson’s Disease

    G. Hey, H. Kamo, G. Rodriguez Garcia, T. Mehta, J. Hilliard, R. Eisinger, A. Ramirez-Zamora (Gainesville, USA)

    Objective: Comparative outcomes between deep brain stimulation (DBS) targets in Early-onset Parkinson’s Disease (EOPD) patients are lacking. This study leverages the University of Florida’s (UF)…
  • 2025 International Congress

    Are There Differences in Non-Motor Outcomes of Parkinson’s Disease Treated with GPi vs. STN Deep Brain Stimulation?

    G. Rodriguez Garcia, G. Hey, A. Martinez Nunez, J. Hilliard, A. Ramirez-Zamora (Gainesville, USA)

    Objective: To evaluate the short-term effects of deep brain stimulation (DBS) of the Globus Pallidus internus (GPi) versus the Subthalamic Nucleus (STN) on non-motor symptoms,…
  • 2025 International Congress

    Tracking The Role Of The Subthalamo-Temporal Network In Speech: A Deep Brain Stimulation-Electroencephalography Study

    M. Mancuso, M. Fahimi, F. Mollaei, S. Maiti, T. Grover, H. Akram, M. Krueger, L. Zrinzo, T. Foltynie, V. Litvak, P. Limousin (London, United Kingdom)

    Objective: To identify deep brain stimulation (DBS)-related disruption of the subthalamic nucleus (STN)–temporal network as a possible source of STN-DBS induced dysarthria. Background: STN-DBS often…
  • 2025 International Congress

    Analgesic Effect of Cannabidiol and Tetrahydrocannabinol(THC) on Pain Sensitivity in Reserpine Model of Parkinson’s Disease

    T. Muhammad, A. Isa, H. Tanko (Kaduna, Nigeria)

    Objective: The objectives of the study were to determine the effect of THC and CBD on:1. Thermal nociceptive threshold in reserpine induced Parkinson’s disease2. Mechanical…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley